TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer Therapy

<table><i>Polyepitope DNA-based cancer vaccines and cross-antigen presentation.</i> After injection of the recombinant polyepitope DNA vaccine into myocyte or keratinocytes, antigenic materials is transferred to dendritic cells (antigen cross-presentation).</table>

BioMed Research International

fig1

Figure 1

Figure 1: TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer Therapy 